Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q8NCW6
UPID:
GLT11_HUMAN
Alternative names:
Polypeptide GalNAc transferase 11; Protein-UDP acetylgalactosaminyltransferase 11; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11
Alternative UPACC:
Q8NCW6; B3KWF4; Q6PCD1; Q9H6C2; Q9H6Z5; Q9UDR8
Background:
Polypeptide N-acetylgalactosaminyltransferase 11, known alternatively as Protein-UDP acetylgalactosaminyltransferase 11 or UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11, plays a crucial role in protein O-linked glycosylation. It specifically catalyzes the transfer of N-acetyl-D-galactosamine to serine or threonine residues on proteins, notably affecting NOTCH1. This modification is pivotal for NOTCH1 activation, which in turn influences the balance between motile and immotile cilia, critical for left-right organ asymmetry.
Therapeutic significance:
Understanding the role of Polypeptide N-acetylgalactosaminyltransferase 11 could open doors to potential therapeutic strategies.